Literature DB >> 2312607

Misinterpretation of iodine uptake in papillary thyroid carcinoma and primary lung adenocarcinoma.

W Langsteger1, P Lind, P Költringer, A Beham, O Eber.   

Abstract

This is the first case report of an iodine-storing metastasising carcinoma of extrathyroidal origin and the simultaneous presence of a papillary thyroid carcinoma. In the course of the disease, an increase in pathological iodine uptake was observed after repeated iodine-131 ablation, so that the original tentative diagnosis of a metastasising, differentiated thyroid carcinoma appeared to be confirmed; moreover, the histological work-up of a femur metastasis--without adequate immunohistochemical assessment--was misinterpreted. What is also remarkable about this case report is a pathological iodine-131 uptake both in the extrathyroidal primary tumor and the metastases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2312607     DOI: 10.1007/bf01612632

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  19 in total

1.  Iodine 131 uptake by primary lung adenocarcinoma. Misinterpretation of 131I scan.

Authors:  M Fernandez-Ulloa; H R Maxon; S Mehta; L J Sholiton
Journal:  JAMA       Date:  1976-08-16       Impact factor: 56.272

2.  Radionuclide study of struma ovarii.

Authors:  E L Yeh; R C Meade; P P Ruetz
Journal:  J Nucl Med       Date:  1973-02       Impact factor: 10.057

3.  Thyroid imaging--mediastinal uptake in thyroid imaging.

Authors:  D S Lin
Journal:  Semin Nucl Med       Date:  1983-10       Impact factor: 4.446

4.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

5.  Uptake of 131I by a papillary meningioma.

Authors:  R A Preisman; S E Halpern; R Shishido; T Waltz; F Callipari; R Reit
Journal:  AJR Am J Roentgenol       Date:  1977-08       Impact factor: 3.959

6.  Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels.

Authors:  M Schlumberger; P Charbord; P Fragu; J Lumbroso; C Parmentier; M Tubiana
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

7.  Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinoma.

Authors:  M A Charles; L E Dodson; N Waldeck; F Hofeldt; N Ghaed; R Telepak; J Ownbey; P Burstein
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

8.  The scope of false-positive iodine-131 images for thyroid carcinoma.

Authors:  D P Greenler; H A Klein
Journal:  Clin Nucl Med       Date:  1989-02       Impact factor: 7.794

9.  The site of leakage of intrafollicular thyroglobulin into the blood stream in simple human goiter.

Authors:  F Gebel; F Ramelli; U Bürgi; U Ingold; H Studer; R Winand
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

10.  Histopathologic types and clinical behaviour of occult papillary carcinoma of the thyroid.

Authors:  S Schröder; N Pfannschmidt; W Böcker; H W Müller; K de Heer
Journal:  Pathol Res Pract       Date:  1984-09       Impact factor: 3.250

View more
  2 in total

1.  False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.

Authors:  Jong-Ryool Oh; Byeong-Cheol Ahn
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

2.  Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study.

Authors:  Yu-Ling Lu; Szu-Tah Chen; Tsung-Ying Ho; Wen-Hui Chan; Richard J Wong; Chuen Hsueh; Shu-Fu Lin
Journal:  World J Clin Cases       Date:  2021-01-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.